This inventor holds 3 USPTO granted patents. Top assignees: Millennium Pharmaceuticals Limited, Millenium Pharmaceuticals, Inc.. Active years: 2001-2003.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:

Years Active: 2001-2003
Title: Levadala Murali Krishna: Innovator in Cyclic Oxygen Compounds
Introduction
Levadala Murali Krishna is a prominent inventor based in Hyderabad, Telangana, India. He has made significant contributions to the field of chemistry, particularly in the development of cyclic oxygen compounds. With a total of 3 patents to his name, his work has implications in pharmaceutical compositions and therapeutic methods.
Latest Patents
One of his latest patents focuses on "Substituted oxygen alicyclic compounds, including methods for synthesis thereof." This invention provides new methods for the preparation of cyclic oxygen compounds, including 2,5-disubstituted tetrahydrofurans, 2,6-disubstituted tetrahydropyrans, 2,7-disubstituted oxepanes, and 2,8-oxocanes. The invention also introduces new cyclic oxygen compounds and pharmaceutical compositions that incorporate these compounds, showcasing his innovative approach to chemical synthesis.
Career Highlights
Throughout his career, Levadala has worked with notable companies such as Millennium Pharmaceuticals Limited and Millennium Pharmaceuticals, Inc. His experience in these organizations has allowed him to refine his skills and contribute to significant advancements in the pharmaceutical industry.
Collaborations
Levadala has collaborated with esteemed colleagues, including Mukund Shankar Chorghade and Mukund Keshao Gurjar. These partnerships have further enriched his research and development efforts in the field of cyclic oxygen compounds.
Conclusion
Levadala Murali Krishna stands out as an influential inventor in the realm of cyclic oxygen compounds. His innovative patents and collaborations reflect his commitment to advancing chemical research and its applications in pharmaceuticals.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile